ADGCX
Price
$16.22
Change
-$0.26 (-1.58%)
Updated
Sep 6 closing price
VSTSX
Price
$255.28
Change
-$4.43 (-1.71%)
Updated
Sep 6 closing price
Ad is loading...

ADGCX vs VSTSX

Header iconADGCX vs VSTSX Comparison
Open Charts ADGCX vs VSTSXBanner chart's image
AB Core Opportunities C
Price$16.22
Change-$0.26 (-1.58%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Instl Sel
Price$255.28
Change-$4.43 (-1.71%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
ADGCX vs VSTSX Comparison Chart
Loading...
VS
ADGCX vs. VSTSX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADGCX is a Buy and VSTSX is a Buy.

FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 1.72T vs. ADGCX (174M). VSTSX pays higher dividends than ADGCX: VSTSX (1.36) vs ADGCX (0.00). ADGCX was incepted earlier than VSTSX: ADGCX (25 years) vs VSTSX (8 years). ADGCX is a more actively managed with annual turnover of: 92.00 vs. VSTSX (2.00). ADGCX has a lower initial minimum investment than VSTSX: ADGCX (2500) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 22.27 vs. ADGCX (15.65). VSTSX return over 5 years is better than : 79.42 vs. ADGCX (5.24).
ADGCXVSTSXADGCX / VSTSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years8 years-
Gain YTD15.08414.276106%
Front LoadN/AN/A-
Min. Initial Investment250050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets174M1.72T0%
Annual Yield % from dividends0.001.36-
Returns for 1 year15.6522.2770%
Returns for 3 years-20.3916.03-127%
Returns for 5 years5.2479.427%
Returns for 10 years-9.50N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MKC83.040.97
+1.18%
McCormick & Company
BBGI0.59N/A
-0.47%
Beasley Broadcast Group
BRKL9.97-0.06
-0.60%
Brookline Bancorp
ENOV43.11-1.12
-2.53%
Enovis Corp
NKTR1.13-0.11
-8.87%
Nektar Therapeutics